Articles tagged "triple-agonist"

Explore all articles about "triple-agonist": evidence-based insights, clinical studies, and GLP-1 peptide research. Updated content on GLP-1 Journal.

Complete guide to retatrutide TRIPLE-G triple agonist of metabolic receptors

GLP-1 Agonists Intermediate

Retatrutide: -28.7% Weight Loss — Full Guide 2026

Retatrutide targets GLP-1, GIP & Glucagon receptors. Up to -28.7% weight loss in 5,800-patient trials. Dosage, results & 2026 availability.

February 26, 2026 16 min read

Peptide vial with holographic molecular structure of retatrutide

GLP-1 Agonists Intermediate

What Is Retatrutide? A Complete Scientific Overview

Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.

February 26, 2026 6 min read